Emily Culme-Seymour, MSc, PhD
Dr. Culme-Seymour has a background in chemistry (BSc, University of Edinburgh and MSc, University College London) and holds a PhD in stem cell bioprocessing from the Advanced Centre for Biochemical Engineering, University College London.
In a step away from the laboratory bench, she is a Director of the London Regenerative Medicine Network (LRMN). Founded in 2005 by two internationally recognized leaders in the field, Dr. Stephen Minger (GE Healthcare) and Prof. Chris Mason (UCL), the LRMN has over 6,000 members and is firmly committed to helping facilitate the building of a competitive and sustainable international cell and gene therapy industry, one that will deliver safe, effective and affordable advanced therapies for the benefit of all.
Dr. Culme-Seymour represents the LRMN on a number of UK and EU consortium projects looking at cell therapy technologies and business modelling, and is a regular author of leading industry-orientated publications in high impact journals including Regenerative Medicine and Cell Stem Cell.
She also sits on the International Society for Cell Therapy’s (ISCT) Executive Committee as Global Treasurer, and uses her knowledge of the cell therapy and regenerative medicine field to advise the internationally-acknowledged stem cell and regenerative medicine lawyers, Lawford Davies Denoon (London, UK), on the more scientific aspects of specific cases.